SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

BALESTRA, Dario
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.586
AS - Asia 2.642
EU - Europa 1.841
SA - Sud America 403
AF - Africa 55
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 9.532
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.464
SG - Singapore 1.059
CN - Cina 725
DE - Germania 404
IT - Italia 384
BR - Brasile 332
PL - Polonia 321
HK - Hong Kong 245
VN - Vietnam 180
GB - Regno Unito 148
UA - Ucraina 145
TR - Turchia 141
FI - Finlandia 134
ID - Indonesia 81
RU - Federazione Russa 66
CA - Canada 63
SE - Svezia 60
MX - Messico 52
IN - India 51
FR - Francia 48
AR - Argentina 35
BE - Belgio 34
ZA - Sudafrica 34
JP - Giappone 33
BD - Bangladesh 23
NL - Olanda 20
ES - Italia 16
RO - Romania 14
CZ - Repubblica Ceca 13
EC - Ecuador 13
KR - Corea 12
IQ - Iraq 11
IR - Iran 11
AT - Austria 8
LT - Lituania 8
MY - Malesia 8
CO - Colombia 7
TW - Taiwan 7
UZ - Uzbekistan 7
MA - Marocco 6
PK - Pakistan 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
IL - Israele 5
PE - Perù 5
KE - Kenya 4
KG - Kirghizistan 4
VE - Venezuela 4
CH - Svizzera 3
DZ - Algeria 3
JO - Giordania 3
NO - Norvegia 3
OM - Oman 3
PT - Portogallo 3
TN - Tunisia 3
UY - Uruguay 3
AU - Australia 2
CR - Costa Rica 2
GE - Georgia 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
NI - Nicaragua 2
NP - Nepal 2
PY - Paraguay 2
SA - Arabia Saudita 2
TH - Thailandia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
EU - Europa 1
GA - Gabon 1
GF - Guiana Francese 1
GH - Ghana 1
GI - Gibilterra 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
IE - Irlanda 1
JM - Giamaica 1
KW - Kuwait 1
LU - Lussemburgo 1
MD - Moldavia 1
NG - Nigeria 1
PH - Filippine 1
TJ - Tagikistan 1
Totale 9.532
Salva come PNG Salva come JPEG
Città #
Singapore 583
Ashburn 502
Fairfield 385
Woodbridge 324
Warsaw 314
Chandler 309
Santa Clara 288
Beijing 279
Hong Kong 239
Houston 229
Ann Arbor 218
Ferrara 176
Munich 169
Seattle 154
Dallas 152
Jacksonville 145
Wilmington 134
Cambridge 126
Los Angeles 104
New York 90
Helsinki 81
Izmir 80
Jakarta 67
Bremen 64
Ho Chi Minh City 64
Princeton 64
Nanjing 63
Boardman 44
Milan 43
Shanghai 37
São Paulo 36
Brussels 32
Mexico City 32
Dearborn 31
Hanoi 28
Toronto 26
London 25
Dong Ket 24
Atlanta 23
Brooklyn 23
Tianjin 23
Montreal 21
San Diego 21
Redwood City 20
Tokyo 20
Frankfurt am Main 19
Nanchang 19
Johannesburg 18
Moscow 18
Chicago 17
Orem 17
Poplar 17
Turku 17
Chennai 16
Shenyang 16
Stockholm 16
The Dalles 15
Rio de Janeiro 14
Denver 13
Falkenstein 13
Mountain View 13
Nuremberg 13
Bologna 12
Changsha 12
Falls Church 12
Jiaxing 11
Manchester 11
San Mateo 11
Hebei 10
Kunming 10
Ankara 9
Brno 9
Rome 9
Biên Hòa 8
Fairford 8
Norwalk 8
Phoenix 8
Auburn Hills 7
Belo Horizonte 7
Boston 7
Buffalo 7
Campinas 7
Columbus 7
Des Moines 7
Dortmund 7
Kuala Lumpur 7
San Jose 7
Secaucus 7
Tashkent 7
Zhengzhou 7
Andover 6
Council Bluffs 6
Florence 6
Fortaleza 6
Guangzhou 6
Hefei 6
Jinan 6
Leawood 6
Ningbo 6
San Francisco 6
Totale 6.482
Salva come PNG Salva come JPEG
Nome #
C6orf10 low-frequency and rare variants in italian multiple sclerosis patients 289
AN EXON-SPECIFIC U1 SMALL NUCLEAR RNA (snRNA) STRATEGY TO CORRECT SPLICING MUTATIONS ASSOCIATED TO HEMOPHILIA B 261
Regulation of a strong F9 cryptic 5'ss by intrinsic elements and by combination of tailored U1snRNAs with antisense oligonucleotides 251
An exon-specific U1snRNA induces a robust factor IX activity in mice expressing multiple human FIX splicing mutants 245
Exploring Splicing-Switching Molecules For Seckel Syndrome Therapy 241
Molecular Basis and Therapeutic Strategies to Rescue Factor IX Variants That Affect Splicing and Protein Function 211
U1-snRNA-mediated rescue of mRNA processing in severe factor VII deficiency 208
Modified U1snRNAs as innovative therapeutic strategy for inherited coagulation factor deficiencies 203
Activation of a cryptic splice site in a potentially lethal coagulation defect accounts for a functional protein variant 202
U1snRNA-mediated rescue of mRNA processing in severe factor VII deficiency 198
An exon-specific U1 small nuclear RNA (snRNA) strategy to correct splicing defects 190
An Altered Splicing Registry Explains the Differential ExSpeU1-Mediated Rescue of Splicing Mutations Causing Haemophilia A 190
Mcl-1 involvement in mitochondrial dynamics is associated with apoptotic cell death 188
A unique exon specific U1snRNA rescues different haemophilia B - causing splicing-defective factor IX variants in mice 179
The chaperone-like sodium phenylbutyrate improves factor IX intracellular trafficking and activity impaired by the frequent p.R294Q mutation 176
Correction of aberrant splicing causing haemophilia B through the combination of compensatory U1snRNAs and antisense oligonucleotides 161
The complete impairment of factor VII gene expression by the IVS6+1g/t mutation is compatible with a severe but not lethal bleeding disorder 155
Aberrant splicing reverts a potentially lethal coagulation deficiency caused by a +1g/t splicing mutation 154
Secretion of wild-type factor IX upon readthrough over F9 pre-peptide nonsense mutations causing hemophilia B 153
A strategy with chaperone-like compounds to restore expression of factor IX variants affected by frequent missense mutations causing hemophilia B 151
Secretion of wild-type factor IX upon readthrough over F9 pre-peptide nonsense mutations causing hemophilia B 151
Disease-causing variants of the conserved+2T of 5 ' splice sites can be rescued by engineered U1snRNAs 148
A very rare simultaneous presence of a ring chromosome 13 and a splicing site mutation on Factor X gene 147
Rescue of coagulation factor VII function by the U1+5A snRNA 144
Rescue of missense and splicing mutations in Haemophilia A by a unique Exon Specific U1snRNA 143
Next-generation sequencing and recombinant expression characterized aberrant splicing mechanisms and provided correction strategies in factor VII deficiency 143
The carboxyl-terminal region of human coagulation factor X as a natural linker for fusion strategies 142
Non-conventional therapeutic strategies for inherited disorders oh hemostasis 140
The carboxyl-terminal region of human coagulation factor X as a novel naturally-occuring linker for fusion strategies 139
The somatic FAH C.1061C>A change counteracts the frequent FAH c.1062+5G>A mutation and permits U1snRNA-based splicing correction 137
An exon-specific small nuclear u1 rna (Exspeu1) improves hepatic otc expression in a splicing-defective spf /ash mouse model of ornithine transcarbamylase deficiency 135
The F7 p.Val22Ile missense mutation affects splicing and can be counteracted by a compensatory U1snRNA 135
Molecular genetics and biology of congenital hemorrhagic diseases 134
A Compensatory U1snRNA Partially Rescues FAH Splicing and Protein Expression in a Splicing-Defective Mouse Model of Tyrosinemia Type I 132
The chaperone-like compound sodium phenylbutyrate improves intracellular trafficking, secretion and coagulant activity of factor IX impaired by the frequent p.R294Q mutation 128
Splicing Mutations Impairing CDKL5 Expression and Activity Can be Efficiently Rescued by U1snRNA-Based Therapy 124
RNA-based therapeutic approaches for blood coagulation factor deficiencies caused by a splicing mutations 121
The Asialoglycoprotein Receptor Minor Subunit Gene Contributes to Pharmacokinetics of Factor VIII Concentrates in Hemophilia A 120
Molecular mechanisms and determinants of innovative correction approaches in coagulation factor deficiencies 119
Dissection of pleiotropic effects of variants in and adjacent to F8 exon 19 and rescue of mRNA splicing and protein function 119
Exon-Specific U1snRNA-Mediated Rescue of Splicing and Missense Changes in Hemophilia A 118
Counteracting the Common Shwachman-Diamond Syndrome-Causing SBDS c.258+2T>C Mutation by RNA Therapeutics and Base/Prime Editing 114
OTC intron 4 variations mediate pathogenic splicing patterns caused by the c.386G>A mutation in humans and spfash mice, and govern susceptibility to RNA-based therapies 109
An advanced method for the small-scale production of high-quality minicircle DNA 105
Contribution of asialoglycoprotein receptor ASGR2 5’ UTR polymorphisms to full-length FVIII concentrate pharmacokinetics 103
MOLECULAR MECHANISMS AND THERAPEUTIC APROACHES FOR RESTORATION OF mRNA TRANSCRIPTION, MATURATION AND TRANSLATION IN INHERITED COAGULATION FACTOR DEFICIENCIES 101
Rescue of coagulation factor VII mRNA processing and protein function by engineered U1+5A snRNA 99
RNA−based therapeutic approaches for blood coagulation factor deficiencies caused by splicing mutations 92
Restoration of coagulation factor IX function impaired by different splicing mutations by a unique exon-specific U1 small nuclear RNA (snRNA) 89
Deep molecular mechanisms of F8 exon 19 variants and translational approaches in Hemophilia A 88
null 87
Base and Prime editing of DNA as a new therapeutic option for Hemophilia A 83
null 79
Elucidation of aberrant SBDS splicing mechanisms to design RNA-therapeutics for Shwachman-Diamond Syndrome 78
null 77
“Compensatory” aberrant splicing supports residual expression levels in severe coagulation factor VII deficiency 75
La terapia genica nelle Malattie emorragiche e trombotiche 75
The asialoglycoprotein receptor ASGR2 5’ UTR polymorphisms influence several parameters of full-length FVIII concentrate pharmacokinetics 75
An engineered U1 small nuclear RNA rescues splicing-defective coagulationF7gene expression in mice 74
Prediction of inhibitor risk in haemophilia A using machine learning 73
null 73
F8 splicing-swithcing molecules for tailored hemophilia A therapies 73
Rescue of a FVIII splicing variant with engineered U1snRNAs 71
Whole-Exome Sequencing in a Family with an Unexplained Tendency for Venous Thromboembolism: Multicomponent Prediction of Low-Frequency Variant Deleteriousness and of Individual Protein Interaction 71
null 71
Rescue of multiple Haemophilia A-causing mutations by a single ExSpeU1: the importance of the genomic context 68
Delivery of a modified U1 small nuclear RNA alleviates splicing-defective coagulation Factor VII expression in mouse models 67
Delivery of a modified U1 small nuclear RNA alleviates splicing-defective coagulation factor VII expression in mouse models 66
New Genome Editing Approaches: Base And Prime Editing To Revert Hemophilia A-Causing Point Mutations 61
Rescue of a hemophilia A-causing FVIII splicing variant via engineered U1SNRNAS 59
Base and Prime Editors as new correction approaches for recurrent Hemophilia A Nonsense Mutations 59
Reverting highly frequent f8 nonsense mutations: base and prime editing approach for hemophilia A 55
null 51
RNA-Based therapeutics for OTC deficiency 48
Rescue of a panel of splicing mutations causing hemophilia A by engineered U1snRNAs 47
Rescue of an F8 splicing variant (c.1752+5 G>C) with engineered U1snRNAs 45
Rescue of a panel of Hemophilia A-causing 5’ss splicing mutations by unique Exon-specific U1snRNA variants 45
A 5’ SPLICE-SITE MUTATION CAUSING MUCOLIPIDOSIS TYPE III CAN BE EFFICIENTLY RESCUED BY U1 SNRNA-BASED THERAPY 44
null 42
Not Just Loss-of-Function Variations: Identification of a Hypermorphic Variant in a Patient With a CDKL5 Missense Substitution 41
La terapia genica nelle terapie emorragiche e trombotiche 32
RESCUE OF A PANEL OF SPLICING MUTATIONS CAUSING HEMOPHILIA A BY ENGINEERED U1-SNRNAS 28
A fixed mutation in the respiratory complex I impairs mitochondrial bioenergetics in the endangered Apennine brown bear 6
DNA base editing corrects common hemophilia A mutations and restores factor VIII expression in in vitro and ex vivo models 2
Totale 9.726
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.684
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 740
Totale 48.424
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021687 0 0 0 0 0 79 128 103 52 166 112 47
2021/2022603 54 75 10 16 25 28 36 20 25 61 32 221
2022/2023734 80 70 20 100 138 81 52 51 76 9 40 17
2023/2024404 18 51 20 22 26 58 21 26 9 19 13 121
2024/20252.024 50 39 177 68 222 249 107 78 346 208 259 221
2025/20262.856 518 214 437 720 754 213 0 0 0 0 0 0
Totale 9.726